31-12-2020 дата публикации
Номер: US20200407438A1
Принадлежит:
Monoclonal antibody that specifically binds IL-1RAcP, or an antigen binding fragment thereof, comprising: 136.-. (canceled)37. A monoclonal antibody that specifically binds to human IL-1RAcP , wherein the monoclonal antibody is capable of inhibiting IL-1 alpha , IL-1 beta , IL-33 , and IL-36 stimulated NFκB activity.38. The monoclonal antibody of claim 37 , capable of binding to murine IL-1RAcP.39. The monoclonal antibody of claim 37 , capable of inhibiting murine IL-1RAcP induced murine NFκB activity.40. The monoclonal antibody of claim 37 , capable of inhibiting NFκB activity stimulated by a complex selected from the group consisting of IL-1β/IL-1R1/IL-1RAcP claim 37 , IL-1α/IL-1R1/IL-1RAcP claim 37 , IL-33/ST2/IL-1RAcP claim 37 , and/or IL-36/IL-36R/IL-1RAcP.41. The monoclonal antibody of claim 37 , capable of inhibiting NFκB activity by 70% or more at a concentration of 5 μg/mL in 293T/17 cell lysates stimulated with 0.5 μg/mL human IL-1 alpha claim 37 , IL-1 beta claim 37 , IL-33 claim 37 , and/or IL-36 claim 37 , relative to the same assay without the monoclonal antibody.42. The monoclonal antibody of claim 37 , capable of inhibiting NFκB activity by 70% or more at a concentration of 5 μg/mL in mouse cell line lysates stimulated with 0.5 μg/mL murine IL-1 alpha claim 37 , IL-1 beta claim 37 , IL-33 claim 37 , and/or IL-36 claim 37 , relative to the same assay without the monoclonal antibody.43. The monoclonal antibody of claim 37 , capable of inhibiting IL-1 alpha claim 37 , IL-1 beta claim 37 , IL-33 claim 37 , and/or IL-36 stimulated luciferase activity in 293T/17 cells claim 37 , wherein luciferase expression is under control of an NFκB reporter gene.44. The monoclonal antibody of claim 37 , wherein ADCC activity is reduced by at least 20% relative to an antibody comprising a wild-type human IgG1 Fc region.45. The monoclonal antibody of claim 37 , comprising reduced affinity to the human FcγRIIIA claim 37 , FcγRIIA claim 37 , and/or FcγRI relative to an ...
Подробнее